Strides Shasun gets USFDA nod to market Dutasteride capsules
Advertisement
New Delhi: Strides Shasun has received approval from the US health regulator to market Dutasteride capsules, used in treating enlarged prostate gland, in the American market.
The company has received approval from the US Food and Drug Administration (USFDA) to market Dutasteride capsules in the strength of 0.5 mg, Strides Shasun said in a regulatory filing.
According to IMS sales data, the US market for Dutasteride capsules is around USD 470 million.
"The product has gone off patent on November 20 and Strides Shasun is amongst the first wave of generic players to receive this approval," the firm said.
The company will manufacture the product at its oral dosage facility at Bengaluru.
The company has received approval from the US Food and Drug Administration (USFDA) to market Dutasteride capsules in the strength of 0.5 mg, Strides Shasun said in a regulatory filing.
According to IMS sales data, the US market for Dutasteride capsules is around USD 470 million.
"The product has gone off patent on November 20 and Strides Shasun is amongst the first wave of generic players to receive this approval," the firm said.
The company will manufacture the product at its oral dosage facility at Bengaluru.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.